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The imminent danger of the Covid-19 pandemic has accelerated research 
in pharmaceuticals that either target the viral Spike proteins fusion with 
ACE2 receptors, or the infectious RNA replication that often overwhelms 
immune defences. The scope of this review was to elucidate the main 
human vulnerabilities to Covid-19, including the accumulation of ACE2 
receptors in testes, adipose tissue, thyroid, heart and kidneys that escalate 
viral affinity in males, the aged, and certain medical conditions, including 
diabetes, CVD, and pulmonary diseases. Pre-existing inflammation inher-
ent in obesity may exacerbate the “cytokine storm,” a rampaging immune 
reaction during the course of Covid-19 that is deleterious to the host. We 
examined the molecular dynamics illustrating the action of new therapeu-
tics necessary for Covid-19 patients; the estradiol advantage hypothesis; 
alternative therapies including hormone replacement procedures and 
mesenchymal stem cells; plus preventive and protective interventions. 
The current perspective also explored the primary components of dysreg-
ulated health predisposing individuals to Covid-19, including hormonal 
imbalance, increased lipids and lipoproteins, thyroid dysfunction, degrad-
ed fitness, and age-related testosterone decline accompanied by cortisol 
increase that provokes stress eating behaviours and weight accumulation. 
Obesity increases the probability of Covid-19 infection due to its abun-
dance of ACE2 receptors; while physical activity may decrease Covid-19 
vulnerability, by reducing fat and increasing muscle mass that manifests 
a relatively inhibited ACE2 expression. Several weight management 
solutions feature lasers and radiofrequency which diminish subcutaneous 
adiposity but do not enhance fitness. A data metanalysis of seven recently 
published clinical studies on 95 obese individuals, 73 males and 22 fe-
males with an average BMI of 30.9, demonstrated visceral fat reduction 
combined with increased skeletal muscle mass. It also revealed a statisti-
cally significant decrease in BMI, lipids, lipoproteins, inflammation and 
toxicity as measured by CRP, Creatinine and Bilirubin respectively, jux-
taposed by optimally healthier levels of Cortisol, Testosterone, Free T3, 
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1. Introduction
Coronavirus is an enveloped viral conglomerate, synthesized by around 30,000 nucleotides, and expressed into a wide variety of diseases that vary 
from influenza, to the severe acute respiratory syndrome 
(SARS), the Middle East respiratory syndrome (MERS), 
and its current evolved version of SARS-Cov-2 or corona-
virus disease 2019 (Covid-19) that has currently infected 
over thirty four million individuals globally, with over a 
million, and constantly rising, mortality rates [1]. 
2. The Covid-19 Affinity for ACE2 Receptors
The Covid-19 two main genes ORF1a and ORF1b encode 
sixteen non-structural proteins, and four structural pro-
teins: the spike (S), divided into S1 / S2 subtypes, mem-
brane (M) and envelope (E) proteins on the viral surface, 
and the nucleocapsid (N) proteins, associated with the 
viral RNA. The S glycoproteins reflect the characteristic 
viral morphology surrounded by “coronas” the Greek 
word for crowns. S1 subunit recognizes and binds to an-
giotensin-converting enzyme 2 (ACE2) receptors, and S2 
releases the fusion peptide to secure the connection [2,3]. 
ACE2 is a membrane-bound enzyme. A Disintegrin And 
Metalloprotease 17 (ADAM17) is able to cleave ACE2 
and cast it into the blood and body fluids, rendering the S1 
/ACE2 fusion less likely [4].
The S1/ACE2 affinity has been documented for over 
15 years [5-7]. The M and E proteins are in charge of the vi-
ral assembly and encapsulation of genetic material respec-
tively [8,9]. The N proteins are intertwined with the viral 
genome and are involved in replicating and transcribing 
the viral RNA, eventually overwhelming the human bio-
molecular network. Due to the imminent threat of the pan-
demic most research has focused on therapeutics rather 
than prevention. A series of studies postulate that theoph-
ylline and pyrimidone can prevent the replicating ability 
of the N protein, by blocking contact of the protein’s 
N-terminus with RNA, thus inhibiting viral multiplica-
tion [10]. Covid-19 does not respond to most nucleotide 
analogues (NA), designed to interfere with viral replica-
tion, due to the Covid-19 inherent Exonuclease (ExoN) 
domain that compromises NAs; however, it appears to be 
responsive to the new NA drug Remdesivir, that features 
the active metabolite, GS441524 [11]. Another therapeutic 
research target is drugs intended to obstruct the Covid-19 
entry into the human system associated with TMPRSS2 
inhibitors, such as camostat mesylate [12], ACE2 receptor 
blockers, or calmodulin antagonists [13]. Nevertheless, 
caution should be taken with ACE inhibitors often used 
to treat diabetes and heart disease. ACE inhibitors prevent 
the conversion of angiotensin I into Angiotensin II, a pep-
tide in the renin-angiotensin system (RAS) that increases 
blood pressure. However, ACE inhibitors do not block the 
ACE2 receptors, because ACE and ACE2 are different 
entities. What can actually stop the virus from binding 
to the ACE2 receptor is ADAM17, which is elevated by 
Angiotensin II. ADAM 17 cleaves ACE2 from the cellular 
membrane. Consequently, ACE2 sheds into body fluids. 
ACE inhibitors ultimately block Angiotensin II production 
resulting in insufficient amounts of ADAM17. Without 
ADAM17, ACE2 receptors cannot shed into body fluids; 
they remain available to fuse with the viral S protein, ulti-
mately infecting the human system [14]. On the other hand, 
there are medical conditions like neurogenic hypertension 
where obstructing Angiotensin II via ACE inhibitors is 
necessary [15]. Hence, the dilemma on whether or not to 
use ACE inhibitors with an individual who suffers from 
both Covid-19 and hypertension. ACE inhibitors will 
reduce Angiotensin II and moderate high blood pressure. 
On the other hand, diminished Angiotensin II will restrict 
ADAM17, and consequently ACE2 shedding that could 
potentially protect against the S/ACE2 fusion, exposing 
the individual to a widespread Covid-19 infection. Ines-
capable side effects are always an issue in treating an un-
healthy body. 
3. Why are Males more Vulnerable to Covid-19?
Research has repeatedly confirmed that Covid-19 exhibits 
a greater affinity for males. ACE2 receptors are again pro-
tagonists in elucidating the increased fatalities observed 
among men rather than women [16,17], due to the high 
incidence of ACE2 receptors in male tissues [18]. ACE2 
is largely expressed in spermatogonia in human testes, 
the androgen producing Leydig cells and Sertoli cells 
involved in the nourishment of spermatozoa in humas 
testes; this ACE2/male tissues bond also exposes the male 
reproductive system to possible malfunction following 
Covid-19 infection [19,20]. Liu et al, analysed both embryon-
ic primordial germ cells (PGCs) and adult Sertoli cells and 
postulated that all testis cells are enriched in ACE2 ex-
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pression starting from the embryonic stage all the way to 
adulthood [21]. There is an additional process increasing the 
probability of infection in males. The androgen receptor 
(AR) that is largely expressed in male tissues, promotes 
the expression of type II transmembrane serine protease 
(TMPRSS2) which acts as a catalyst priming both the 
viral S glycoprotein and the organ’s ACE2 receptor, thus 
accelerating the fusion of coronavirus’ Spike (S) protein 
with ACE2 receptors, inevitably infecting the body with 
Covid-19 [22-24]. 
4. The Importance of ACE2 Expression in Vi-
tal Organs
Although ACE2 receptors, prepared by proteases like 
TMPRSS2 may be the point of viral entry, autopsies of 
Covid-19 patients revealed a higher incidence of the 
cathepsin L1 protein (CTSL) rather than ACE2 receptors 
in the lungs. These investigators found a dysfunctional 
biological landscape characterized by deteriorated protein 
translation and lipid metabolism as well as substantial-
ly damaged lungs, kidneys, spleen, liver, heart, thyroid, 
and testes featuring a reduced number of Leydig cells [25]. 
Their results, however may reflect the lethal aftereffects of 
Covid-19 rather than the initial phase of the infection. In 
fact, CTSL is another protease facilitating the fusion of the 
Covid-19 S protein with ACE2 receptors [26]. Additionally, 
Li et al. who examined 31 different human tissues, found 
that ACE2 expression in the lungs was in fact moderate [27], 
suggesting the possibility that the increased CTSL in the 
lungs found post-mortem may reflect the virus exploiting 
CTSL to increase its probability of successful fusion with 
ACE2 receptors. Li et al. found that ACE2 receptors were 
more abundant in testes, adipose tissue, heart, thyroid and 
kidneys with a minimum expression in the muscles, blood 
and blood vessels. Although ACE2 receptors in most vi-
tal organs were equivalent in males, females, old, young, 
Asian and non-Asian populations, the immune responses 
widely varied in the four groups delineating greater vul-
nerability among the male and older groups. The increased 
incidence of ACE2 in male tissues explains the younger 
men’s susceptibility to Covid-19; while the dimension of 
immunity, including evidence that age-related testosterone 
decline affects the activity of respiratory muscles, eluci-
dates the Covid-19 vulnerability of older males who man-
ifest an age-related testosterone decline [28,29]. 
Overall, focusing on one component, for example tes-
tosterone, will leave us with contradictory findings, where 
both high and low testosterone may be associated with 
increased Covid-19 vulnerability due to the multifacto-
rial causation of viral infections. A more comprehensive 
perspective is necessary that spotlights increased ACE2 
expression in other tissues, differential immunity respons-
es between males / females, the old /young, differential 
levels of inflammation as well as the very important di-
mension of hormonal imbalance that becomes prominent 
with aging.
One aspect of hormonal imbalance, delineated by the 
thyroid disorder, has been directly connected to Covid-19, 
indicating a malfunction in transforming free thyroxine 
(T4) to free triiodothyronine level (Free T3) [30,31]. Addi-
tionally, thyroid dysregulation affects disorders presenting 
the highest incidence of Covid-19 mortality rates, such as 
Diabetes and CVD [32-35]. Adrenals have a moderate ACE2 
expression, yet, research reveals that increased levels of 
the stress hormone, cortisol, decreases the chances of sur-
viving Covid-19. High cortisol concentrations have been 
linked to diabetes and heart disease [36-38]. 
5. Hormones, Inflammation and Alternative 
Treatment Modalities
The lower number of overall Covid-19 female fatalities 
has highlighted the anti-inflammatory effects of estradiol 
[39]. There is evidence from animal models that estradiol 
is associated with a twofold decrease of ACE2 receptors 
in the female kidney [40]. Normally, ACE2 is highly ex-
pressed in the kidneys, therefore, the estradiol suppression 
of ACE2 receptors in the female kidneys may be partly 
responsible for their lower mortality rates. A recent review 
examined evidence that the anti-inflammatory effects of 
steroids 17b-estradiol (E2) and progesterone (P4) may 
be able to counteract the deleterious effects of the hyper-
inflammatory state associated with the cytokine storm, 
where white blood cells indiscriminately attack both the 
virus and the vital organs that contain it [41]. Interestingly, 
a study of 68,466 Covid-19 cases found that premeno-
pausal females had a 15% higher incidence of infection 
than males while postmenopausal women evidenced an 
equivalent susceptibility to men; yet, males demonstrated 
50% higher mortality rates. In other words, premenopaus-
al women were slightly more susceptible to the disease 
than men, however, they were able to overcome it more 
efficiently than men. Fatality risk was reduced by 50% 
in postmenopausal women treated with estradiol. How-
ever, estradiol treatment had no effect on premenopausal 
women who manifested optimal estradiol levels in their 
systems [42]. In conclusion, indiscriminate administration 
of estradiol to all women may not have the expected 
desirable effects with regards to Covid-19. Importantly, 
the evidence of increased susceptibility risk among pre-
menopausal women should be taken into consideration. 
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This higher susceptibility may be due to the inflammatory 
C-reactive protein (CRP) being higher in females than 
males, as a survey on 22,000 individuals indicated [43]. The 
hypothesis being that the higher the initial inflammatory 
state, the higher the possibility of contracting the virus; 
however due to estradiol’s anti-inflammatory influence 
counteracting the effects of the cytokine storm, female 
fatality rates are lower than men. Earlier research indicat-
ed that estradiol and cyproterone acetate (CPA) hormone 
therapy on postmenopausal women had no effects on 
CRP; however, estradiol plus norethindrone acetate and 
levonorgestrel significantly increased CRP unlike the 
no-treatment control group that displayed no CRP changes 
[44]. These results suggest caution with hormonal replace-
ment therapy cocktails (HRT) that can potentially result in 
hormonal imbalance, and possibly trigger unwanted pro-
cesses increasing inflammation. Silvestri et al reported that 
although HRT raises CRP, it actually appears to decrease 
other inflammatory markers such as interleukin-6 (IL-6), 
soluble thrombomodulin (TM) plasma levels, and E-selec-
tin concentrations [45]. TM is often associated with organ 
failure[46] and the risk of haemorrhage[47], which signify the 
presence of inflammation.  On the other hand, IL-6 can act 
as a pro-inflammatory cytokine and an anti-inflammatory 
myokine, so again, results may have been confounded by 
the sample selection threat to validity. Moreover, CRP has 
been traditionally featured as a consistently reliable mark-
er of inflammation [48]. In conclusion, HRT should take 
into consideration age, health status, and the possibility 
of inducing hormonal imbalance or initiating undesirable 
processes leading to inflammation. 
A recent study postulates that human umbilical cord 
mesenchymal stem cells (MSC) had a positive effect on 
one Covid-19 patient [49]. Additional research reported 
a significant improvement in respiratory symptoms and 
reduced inflammation after injecting eleven Covid-19 pa-
tients with MSC [50]. However, the samples of both studies 
were too small to serve as valid and conclusive evidence 
that MSC can be clinically useful in the treatment of 
Covid-19. 
6. Covid-19 Preference for Adipose Tissue
The primary expression of ACE2 receptors in adipose 
tissue, heart and thyroid is consistent with research evi-
dencing higher Covid-19 fatality rates among obese indi-
viduals, and patients suffering from cardiovascular disease 
(CVD), hypertension, and diabetes [51-55]. The relatively 
lower ACE2 expression in muscle tissues renders physical 
activity, and exercise alternatives as optimal protective 
methods to safeguard health [56,57]. 
The need for exercise or an equivalent alternative be-
come prominent in light of evidence that body mass index 
(BMI) over 25 is associated with a fatality rate increase of 
88% after contracting Covid-19 [58]. Visceral adiposity has 
been associated with inflammatory markers like C-reactive 
protein (CRP), tumour necrosis factor-a (TFN-a) and in-
terleukin-6 (IL-6) that have been prominently featured in 
Covid-19 patients [59-62]. Age is positively correlated both 
with visceral adipose tissue increase and CRP, TFN-a and 
IL-6 [63]. Covid-19 disease severity and poor prognosis are 
closely associated with elevated inflammatory markers 
including interleukins (IL-2, IL-6, IL-8), CRP and TNF-a 
[65]. Interleukins, tumour necrosis factors, and interferons 
are involved in the “cytokine storm syndrome” (CSS), an 
overzealous immune defensive activity that spirals out of 
control damaging the vital organs of the host [64-66]. The 
higher the initial level of inflammation, due to obesity or 
other factors, the greater the chance of the lethal effects 
of the cytokine storm. The fusion of the S Covid-19 gly-
coprotein with the ACE-2 receptors that are abundant in 
adipose tissue, trigger a chain of events, such as overpro-
duction of Angiotensin II, a proinflammatory cytokine, 
that promotes A Disintegrin And Metalloproteinase 17 
(ADAM17). ADAM17 is instrumental in the ACE2 shed-
ding process that may reduce viral entry into the body, 
therefore, acting as a protective agent; yet, as Angioten-
sin II increases ADAM17, it ultimately activates TNF-a, 
and amplifies IL-6 along with other parameters, rapidly 
progressing to a hyperinflammatory state that precipitates 
multi-organ injury or failure [67-69]. 
In conclusion, Covid-19 is a complex medical ‘double 
edged-sword’ posing major pharmaceutical dilemmas, 
progressing globally with infections and fatalities, de-
spite the diagnostic and drug research it has accumulated, 
which have not yet guaranteed a complete cure. Hence, 
the necessity of gearing some of Covid-19 research to-
wards prevention. An obvious target is weight manage-
ment to reduce obesity that is featured as one of the major 
factors increasing global Covid-19 susceptibility and mor-
tality rates.
7. Lasers and Radiofrequency Techniques for 
Weight Loss
A number of radiofrequency (RF) technologies claim vir-
tually instant subcutaneous lipolysis, however, they offer 
no clear data on long term results regarding weight re-
bound. Additionally, they present no evidence supporting 
increased muscle mass or detoxification caused by the ac-
tual technology rather than relying on exercise, or the effi-
ciency of the body to perform this function [70-75]. Research 
that combines RF and cryolipolysis on the reduction of 
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subcutaneous fat, reported improvement in 73.46% of the 
patients, a statistically non-significant result; 22.44% of 
these patients experienced no change, and 4.08% of them 
disclosed that RF had deleterious effects on their appear-
ance [76]. Most RF lipolysis studies primarily address the 
subcutaneous fat area. One study published in the Cairo 
University Bulletin, which is not a peer reviewed journal, 
claim visceral fat reduction, however, there is no evidence 
specific to visceral fat, and upon examination it appears 
that the reduction seen pertained to overall fat [77].
Reports on the medical uses of RF concur on the in-
creased presence of inflammation. A study on 130 patients 
delineated a significant increase in the inflammatory 
marker CRP at the level of p<0.01 statistical significance 
[78]. Research exploring RF medical interventions revealed 
an increase in both oxidative stress and inflammation bio-
markers [79]. Another study on ninety patients undergoing 
RF treatments documented elevated creatine kinase, CRP, 
Troponin-P and increased fibrinogen [80]. This data is not 
directly connected to Covid-19 patients, but it cautions 
against the application of RF technologies on this popula-
tion, or even preventatively, since RF induced increase of 
inflammation and prothrombotic markers could be delete-
rious to the overall health status.
Laser technology has also claimed subcutaneous lipoly-
sis [81-89]. A review evaluating laser induced complications 
on 537 cases found only one case of skin infection, and 
four skin burns, rendering laser weight loss procedures 
relatively safe [90,91]. A more detailed review, however, 
has compiled a number of side effects following laser 
treatments, including skin burns, dysesthesia, superficial 
thrombophlebitis, hematoma, nerve injury, and some 
rare incidences of pulmonary embolism [92]. A number of 
investigators make claims about the anti-inflammatory ef-
fects of low level laser therapy (LLLT) and present cases 
of pain analgesia, reduced oedema, and improvement of 
some pulmonary diseases [93-99]. A recent LLLT review pro-
poses that this type of therapy should be used to counter-
act the cytokine storm of Covid-19, however they present 
no clinical studies involving Covid-19 patients (100). 
Some investigators have reported visceral fat reduction 
after combining LLLT and exercise; yet, it is not clear 
whether the effects on visceral fat were due to the laser 
rather than the exercise, and a replication of this study by 
the same investigators did not substantiate the evidence of 
the visceral fat reduction [101,102].
8. Exercise and its Alternative
Physical fitness safeguards health and protects the body 
before contracting the virus, as well as following infection 
by reinforcing immunity during the initial stages of the 
disease [103-107]. There is evidence that engaging in mod-
erate intensity gymnastics reduces the risk of respiratory 
symptoms [108-110]. Research that explored the immunity 
status of 273 runners demonstrated that regular sustained 
physical activity resulted in the lowest incidence of viral 
infections [111]. On the down side, exploration of viscer-
al fat reduction via exercise has demonstrated modest 
findings. One study found a statistically insignificant 
decrease of visceral fat and fatty liver that was not accom-
panied by weight reduction [112]. Research on 160 healthy 
Korean adults used computed tomographic scanning to 
test the results of exercise on inflammation and visceral 
fat; they found that visceral fat was the best predictor of 
inflammation as measured by CRP levels and insulin re-
sistance. These investigators reported significantly lower 
visceral fat, yet in the absence of any improvement in 
physical fitness or BMI decrease [113]. In conclusion, exer-
cise appeared to help, but it required extensive commit-
ment and long term effort to reach optimal results.  
On the other hand, there is some evidence that exercise 
may trigger asthma [114]. Strenuous exercise is connected 
to increased cortisol, which as noted previously, is associ-
ated with diabetes, heart disease and increased Covid-19 
mortality rates [115,116]. Strenuous gymnastics result in an 
inverse cortisol/testosterone relationship, where both 
cortisol increase and testosterone decrease are bound to 
elevate stress, fatigue, and hunger which ultimately under-
mines the advantages of exercise [117,118]. Cortisol induced 
stress-eating behaviours are reinforced by the decrease 
of the anorexic hormone, leptin, that is compromised by 
strenuous activity [119]. Additionally, interleukin-6 appears 
to increase following excessive exercise that is often 
necessary to reduce visceral fat, [120] a problematic event, 
since an initial high inflammatory state may reinforce the 
occurrence of the Covid-19 induced cytokine storm after 
infection. 
A series of recent studies report statistically significant 
decreases in lipids, visceral fat and the absence of hepatic 
steatosis in patients previously diagnosed with fatty liv-
er. Specifically, the clinical trials delineate a statistically 
significant decrease in the very-low density lipoprotein 
(VLDL) and triglycerides, juxtaposed by an increase in 
the high-density lipoprotein (HDL). Additionally, they 
demonstrate increased fitness and normalized levels of 
Insulin Growth Factor-1 (IGF-1), the metabolic hormone 
Triiodothyronine (Free T3), Insulin, Testosterone, Cor-
tisol, the anorexic hormone Leptin and the orexigenic 
one, Ghrelin, after 10-12 treatments with an alternative to 
exercise, originally invented in London University. Some 
of these studies rely on small samples demonstrating re-
duced inflammation and oxidative damage as measured 
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by wound healing, neuropathic pain analgesia, as well as 
statistically significant decreases in CRP, creatinine, and 
bilirubin [121-129]. We used T-tests for dependent means to 
analyse the raw data derived from 95 subjects, 73 females 
and 22 males, that participated in these clinical trials. 
Table 1 depicts the statistical significance values, and the 
average percentage increase or decrease of each variable. 
Thirty-five out of the 95 subjects were healthy adults. The 
remaining sixty patients suffered by at least one or more 
medical disorders: Fifteen were diagnosed with diabetes, 
twenty with prediabetes; eleven had hypertension, ten 
presented hyperphagia, fifteen had hepatic steatosis and 
twenty-one had hypothyroidism.
9. Discussion
Covid-19 is a global lethal pandemic that has stirred an 
enormous body of clinical data including both therapeutic 
methods and preventive interventions. Research primarily 
targets the Covid-19 point of entry via the fusion of the S 
glycoprotein with ACE2 receptors, or the involvement of 
the N protein in the RNA viral replication. The abundance 
of ACE2 receptors in adipose tissue and the testes renders 
obese males highly susceptible to decease. The heart, 
liver, and thyroid are also enriched with ACE2 expres-
sion, precipitating increased mortality rates among CVD 
and diabetic patients, as well as overweight individuals 
with excess visceral fat that often results in non-alcoholic 
hepatic steatosis. The diminished incidence of ACE2 re-
ceptors in muscle tissue spotlights physical activity or its 
alternatives as a protective shield against the virus, due to 
their propensity to utilize fat as an energy source to build 
muscle. However, strenuous activity can be detrimental 
by increasing inflammation and the stress hormone, cor-
tisol, while decreasing testosterone and the anorexic hor-
mone leptin leading to increased food consumption, and 
Table 1. T-Tests Statistical Significance Results on Blood Tests and Measurement Variables of a totals of 95 overweight 
individuals with an average BMI>25, after 12 treatments with a new, health enhancing methodology
Mean S2 =SS/df T Value p Value Probability Comments
VLDL 25 HA / 20 PMD -1.19 0.31 -9.35 <0.00001 P<0.00001 VLDL was Reduced by -41.59%
Triglycerides 25 HA / 40 PMD -1.25 0.61 -6.94 <0.00001 P<0.00001 Triglycerides were reduced by -31.96
HDL 30 PMD 9.34 23.66 10.52 <0.00001 P<0.00001 HDL was increased by +19%
Free T-3 45 HA / 10 PMD 0.93 0.13 11.62 <0.00001 P<0.00001 Free T3 was increased by +41.07% WNR
Leptin 10 HA / 10 PMD 1.82 2.68 4.98 0.00004 P<0.0001 Leptin increased by +13.41% WNR
Ghrelin 10 HA / 10 PMD -43.55 962.79 -6.28 <0.00001 P<0.00001 Ghrelin decreased by  -8.28% WNR
Bilirubin 10 PMD -0.08 0.12 -7.26 0.00002 P<0.0001 Bilirubin decreased by -69.23% WNR
Creatinine 10 PMD -0.24 0.04 -4.06 0.00143 P<0.01 Creatinine decreased by -19.67% WNR
CRP 10 PMD -0.59 0.16 -4.72 0.00055 P<0.001 CRP decreased by -36.87% WNR
Cortisol 35 HA -18.26 142.98 -6.66 <0.00001 P<0.00001 Cortisol decreased by  -13.08% WNR
Testosterone 35 HA 2.9 4.6 6.05 <0.00001 P<0.00001 Testosterone increased by +43% WNR
VAT 35 HA / 60 PMD -4.68 7.12 -13.6 <0.00001 P<0.00001 VAT decreased by -21.95%
Overall Fat 50 PMD -4.98 6.43 -13.88 <0.00001 P<0.00001 Overall Fat decreased by -13.42%
BMI 60 PMD -2.3 1.28 -15.73 <0.00001 P<0.00001 BMI decreased by -10%
BMR 10 HA 91.6 3782.04 4.71 0.00055 P<0.001 BMR increased by +91.60%
SMM 35 HA / 15 PMD +4.3 0.45 +13.49 <0.00001 P<0.00001 SMM increased by +40.7%
IGF-1 35 HA <0.00001 P<0.00001 IGF-1 increased by +19.68
Blood Glucose Fasting 15 D -61.88 7675.12 -8.11 <0.00001 P<0.00001 50% normal after 12 treatments
Blood Glucose PP 15 D -63.07 7353.79 -845 <0.00001 P<0.00001 33% normal after 12 treatments
Insulin Fasting 20 PD -30.71 5961.47 −2.97 0.01031 P < 0.01 100% normal after 12 treatments
Insulin PP 20 PD −129.43 18065.62 −7.20 0.00009 P < 0.0001 100% normal after 12 treatments
Weight Loss 10 HA / 50 PMD -6.49 9.34 -11.63 <0.00001 P<0.00001 Average Weight loss -7.22 kilograms
Above Umbilicus Measurement  
50 PMD -8.04 9.54 18.22 <0.00001 P<0.00001 Average cm loss -9.375 cm
Umbilicus Measurement 50 
PMD -8.93 12.31 -17.81 <0.00001 P<0.00001 Average cm loss -9.1 cm
Below Umbilicus Measurement 
50 PMD -9.33 20.1 -14.56 <0.00001 P<0.00001 Average cm loss -9.635 cm
Abbreviations: WNR: Within Normal Range / CRP: C-Reactive Protein / HA: Healthy Adults / PMD: Patients with Medical Disorder / VLDL: Very-
Low Density Lipoprotein / HDL: High Density Lipoprotein / VAT: Visceral Adipose Tissue / BMI: Body Mass Index / BMR: Basal Metabolic Rate / 
SMM: Skeletal Muscle Mass / PP: Postprandial / IGF-1: Insulin Growth Factor-1 / D: Diabetics / PD Prediabetics
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eventual fat accumulation. This process is exacerbated by 
age-related testosterone decline, juxtaposed by upsurged 
cortisol. The anti-inflammatory properties of estradiol are 
highlighted within the moderation of hormonal balance. 
Overall, adiposity is featured as the epicentre of inflam-
mation, which increases the probability of the cytokine 
storm rampaging the body, following Covid-19 infection. 
This lethal process is facilitated and accelerated by the 
plenitude of ACE2 receptors in adipose tissue. 
There are several weight management techniques, 
including different versions of lasers and RF, some of 
which may escalate inflammatory conditions, and none 
of which contributes to increased fitness. A metanaly-
sis of recently published clinical trials that included 95 
individuals, 73 females and 22 males with an average 
BMI of 30.9, featured an exercise alternative as a protec-
tive method to safeguard immunity with a special focus 
on prevention. None of these clinical trials involved 
Covid-19 patients or claimed to address a Covid-19 ther-
apeutic intervention. The purpose was defined as investi-
gating effective methods to reinforce health by sufficient-
ly decreasing visceral adiposity and lipoproteins, while 
increasing skeletal muscle mass and overall hormonal 
balance. One of the clinical trials [124] on twenty diabetic 
and prediabetic patients presented evidence of a signif-
icant reduction in both fasting and postprandial glucose 
and insulin. Seven patients with hepatic steatosis under-
went sonography that revealed no fatty liver after twelve 
treatments. Ten of the subjects diagnosed with hyperpha-
gia, reported normal appetite after 12 treatments. IGF-1, 
Free T3, Leptin and Testosterone were elevated, yet they 
remained within the normal range. Cortisol and Ghrelin 
decreased, yet without descending into abnormality. 
Despite its significant results the twelve procedures 
performed in these clinical trials demonstrated that the 
higher the degree of obesity the less the chance that the 
BMI decrease was within the confines of optimal weight, 
possibly indicating the necessity for more treatments or 
the inclusion of a well-controlled diet plan. Additionally, 
most of the studies did not use ultrasound or magnetic 
resonance imaging techniques that are experimentally 
more reliable in assessing visceral adiposity.
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